Biomar Microbial Technologies – Product Pipeline Review

Global Markets Direct’s, ‘Biomar Microbial Technologies – Product Pipeline Review – 2016’, provides an overview of the Biomar Microbial Technologies’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Biomar Microbial Technologies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Biomar Microbial Technologies

The report provides overview of Biomar Microbial Technologies including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Biomar Microbial Technologies’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Biomar Microbial Technologies’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Biomar Microbial Technologies’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Biomar Microbial Technologies

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Biomar Microbial Technologies’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Biomar Microbial Technologies Snapshot 7

Biomar Microbial Technologies Overview 7

Key Facts 7

Biomar Microbial Technologies - Research and Development Overview 8

Key Therapeutic Areas 8

Biomar Microbial Technologies - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Biomar Microbial Technologies - Pipeline Products Glance 13

Biomar Microbial Technologies - Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Biomar Microbial Technologies - Drug Profiles 15

IB-05202 - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

IB-06202 - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

IB-07A037 - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

IB-07A081 - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

IB-07A085 - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

IB-08C175 - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

IB-08C179 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

IB-09A0133 - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

IB-09A149 - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

IB-10A111 - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

IB-10C179 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

IB-12A157 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

Small Molecule 1 for Oncology - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

Small Molecule 2 for Oncology - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

Small Molecule 3 for Oncology - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

Small Molecules 4 for Oncology - Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

Small Molecules for Aspergillosis and Candidiasis - Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

Small Molecules for Bacterial Infections - Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

Small Molecules for Glioblastoma - Drug Profile 33

Product Description 33

Mechanism Of Action 33

R&D Progress 33

Small Molecules for Multi Drug Resistant Staphylococcus Aureus Infections - Drug Profile 34

Product Description 34

Mechanism Of Action 34

R&D Progress 34

Small Molecules for Neuropathic Pain - Drug Profile 35

Product Description 35

Mechanism Of Action 35

R&D Progress 35

Small Molecules for Tuberculosis - Drug Profile 36

Product Description 36

Mechanism Of Action 36

R&D Progress 36

Small Molecules to Antagonize G-Protein-Coupled Receptors for Oncology - Drug Profile 37

Product Description 37

Mechanism Of Action 37

R&D Progress 37

Small Molecules to Antagonize VEGF Receptor for Oncology - Drug Profile 38

Product Description 38

Mechanism Of Action 38

R&D Progress 38

Small Molecules to Inhibit Kinase for Oncology - Drug Profile 39

Product Description 39

Mechanism Of Action 39

R&D Progress 39

Small Molecules to Inhibit NIK for Multiple Sclerosis - Drug Profile 40

Product Description 40

Mechanism Of Action 40

R&D Progress 40

Small Molecules to Inhibit tRNA for Bacterial Infections - Drug Profile 41

Product Description 41

Mechanism Of Action 41

R&D Progress 41

Biomar Microbial Technologies - Pipeline Analysis 42

Biomar Microbial Technologies - Pipeline Products by Target 42

Biomar Microbial Technologies - Pipeline Products by Route of Administration 43

Biomar Microbial Technologies - Pipeline Products by Molecule Type 44

Biomar Microbial Technologies - Pipeline Products by Mechanism of Action 45

Biomar Microbial Technologies - Dormant Projects 46

Biomar Microbial Technologies - Locations And Subsidiaries 47

Head Office 47

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

List of Tables

Biomar Microbial Technologies, Key Facts 7

Biomar Microbial Technologies – Pipeline by Indication, 2016 9

Biomar Microbial Technologies – Pipeline by Stage of Development, 2016 11

Biomar Microbial Technologies – Monotherapy Products in Pipeline, 2016 12

Biomar Microbial Technologies – Preclinical, 2016 13

Biomar Microbial Technologies – Discovery, 2016 14

Biomar Microbial Technologies – Pipeline by Target, 2016 42

Biomar Microbial Technologies – Pipeline by Route of Administration, 2016 43

Biomar Microbial Technologies – Pipeline by Molecule Type, 2016 44

Biomar Microbial Technologies – Pipeline Products by Mechanism of Action, 2016 45

Biomar Microbial Technologies – Dormant Developmental Projects,2016 46

List of Figures

List of Figures

Biomar Microbial Technologies – Pipeline by Top 10 Indication, 2016 9

Biomar Microbial Technologies – Pipeline by Stage of Development, 2016 11

Biomar Microbial Technologies – Monotherapy Products in Pipeline, 2016 12

Biomar Microbial Technologies – Pipeline by Target, 2016 42

Biomar Microbial Technologies – Pipeline by Molecule Type, 2016 44

Biomar Microbial Technologies – Pipeline Products by Mechanism of Action, 2016 45

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports